Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bright Minds Biosciences Inc (DRUG.CN)

Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 754,869
  • Shares Outstanding, K 7,089
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,802 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -3.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.56

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.8100 +46.26%
on 11/07/25
106.4900 unch
on 12/05/25
+33.6800 (+46.26%)
since 11/05/25
3-Month
55.2200 +92.85%
on 09/09/25
106.4900 unch
on 12/05/25
+45.4900 (+74.57%)
since 09/05/25
52-Week
33.0100 +222.60%
on 06/30/25
106.4900 unch
on 12/05/25
+52.9800 (+99.01%)
since 12/05/24

Most Recent Stories

More News
Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

-- Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; distinguished global experts in PWS, will support the Company’s PWS program, which...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

-- Company will host a webcast at 10am ET on November 6, 2025, to discuss its Phase 2a study to assess efficacy, safety and tolerability of BMB-101 (NOVA Study) for the treatment of patients with Prader-Willi...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences to Present at Upcoming Conferences

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

/CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") announces that it has entered into an equity distribution...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG) today announced compelling preclinical results for its investigational compound BMB‑201, in a validated isosorbide...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences to Present at Upcoming Conferences

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective...

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101

DRUG : 80.50 (+11.03%)
DRUG.CN : 106.4900 (+6.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders...

See More

Key Turning Points

3rd Resistance Point 112.8633
2nd Resistance Point 109.6767
1st Resistance Point 108.0833
Last Price 106.4900
1st Support Level 103.3033
2nd Support Level 100.1167
3rd Support Level 98.5233

See More

52-Week High 106.4900
Last Price 106.4900
Fibonacci 61.8% 78.4206
Fibonacci 50% 69.7500
Fibonacci 38.2% 61.0794
52-Week Low 33.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar